Prism Scientific Labs

HYTN Innovations Inc (CSE:HYTN), a leader in the development and manufacture of psychoactive and psychotropic compounds, including cannabis and psilocybin, has completed the acquisition of Prism Scientific Labs Inc, as announced in their July 19 press release. This strategic move is intended to...